Who
Jay S. Stout
Chief Technology Officer
Company insider
Files Form 4 as: Chief Technology Officer, Immunovant; SVP, Technical Operations, Versartis.
In numbers
- Trades disclosed
- 54
- Buys
- 0
- Sells
- 20
- Bought
- $0
- Sold
- $5.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 3 Apr 2017
- Last trade
- 21 Oct 2026
- Last filed
- 23 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Oct 2026filed 23 Oct 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $75K2,595 at $28.94 | filing |
| 7 Oct 2026filed 9 Oct 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $71K2,213 at $32.06 | filing |
| 7 Oct 2026filed 9 Oct 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $51K1,596 at $32.06 | filing |
| 23 Jul 2026filed 24 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $111K2,857 at $38.69 | filing |
| 23 Jul 2026filed 24 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $111K2,857 at $38.69 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $75K1,906 at $39.53 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $4,199105 at $39.99 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $55K1,399 at $39.53 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $3,07977 at $39.99 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $75K1,906 at $39.53 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $4,199105 at $39.99 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $55K1,399 at $39.53 | filing |
| 8 Jul 2026filed 10 Jul 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $3,07977 at $39.99 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $1.3M33,277 at $38.18 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $262K6,723 at $38.94 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $1.3M33,277 at $38.18 | filing |
| 26 Jun 2026filed 26 Jun 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $262K6,723 at $38.94 | filing |
| 23 Apr 2026filed 24 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $82K2,754 at $29.62 | filing |
| 23 Apr 2026filed 24 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $82K2,754 at $29.62 | filing |
| 8 Apr 2026filed 10 Apr 2026 | IMVT ImmunovantBiotechnology | SEC FORM 4 Sold | $214K8,614 at $24.83 | filing |
News
No headline names them, or the companies they trade most, lately.